Diversify Wealth Management LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 127.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,038 shares of the medical equipment provider’s stock after purchasing an additional 12,912 shares during the period. Diversify Wealth Management LLC’s holdings in Intuitive Surgical were worth $10,456,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Valmark Advisers Inc. grew its position in Intuitive Surgical by 8.9% during the first quarter. Valmark Advisers Inc. now owns 1,195 shares of the medical equipment provider’s stock worth $551,000 after buying an additional 98 shares during the period. Pittenger & Anderson Inc. lifted its position in shares of Intuitive Surgical by 1.8% during the 1st quarter. Pittenger & Anderson Inc. now owns 61,433 shares of the medical equipment provider’s stock valued at $28,320,000 after acquiring an additional 1,068 shares during the period. Carnegie Investment Counsel lifted its position in shares of Intuitive Surgical by 92.7% during the 1st quarter. Carnegie Investment Counsel now owns 3,253 shares of the medical equipment provider’s stock valued at $1,500,000 after acquiring an additional 1,565 shares during the period. UNIVEST FINANCIAL Corp boosted its stake in shares of Intuitive Surgical by 7.5% during the 1st quarter. UNIVEST FINANCIAL Corp now owns 9,180 shares of the medical equipment provider’s stock worth $4,232,000 after acquiring an additional 638 shares in the last quarter. Finally, 180 Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 5.2% during the 1st quarter. 180 Wealth Advisors LLC now owns 4,488 shares of the medical equipment provider’s stock worth $2,069,000 after acquiring an additional 223 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
More Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: BMO Capital Markets upgraded Intuitive Surgical to strong-buy, which can help sentiment by signaling confidence in the stock’s long-term outlook. Zacks.com
- Positive Sentiment: Investor interest remains supported by expectations that July 16 results will show higher sales and EPS, with strong adoption of the da Vinci 5 surgical robot seen as a key growth driver. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
- Neutral Sentiment: Evercore ISI cut its price target to $430 from $480 while keeping an In Line rating, suggesting the company still has growth potential but investors may be more cautious on near-term upside. Is Intuitive Surgical (ISRG) One Of MedTech’s Best AI Stock To Buy?
- Neutral Sentiment: Options traders are pricing in a wide range of outcomes for ISRG ahead of earnings, reflecting uncertainty around how the report and guidance could move the stock. Just How Much Risk Is Built Into ISRG Stock?
- Negative Sentiment: Investors are weighing possible margin pressure, which could limit enthusiasm even if revenue and earnings grow next quarter. ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
Intuitive Surgical Stock Down 1.2%
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.
Insider Activity at Intuitive Surgical
In related news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock valued at $3,059,135 over the last quarter. Insiders own 0.60% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently weighed in on ISRG shares. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. BTIG Research reiterated a “buy” rating and set a $574.00 target price on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. TD Cowen lowered their target price on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Raymond James Financial dropped their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Finally, Leerink Partners cut their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $569.20.
Get Our Latest Stock Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
- Why “Big Short” Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
